RxDoctor Payments DataLook up a doctor →

Jeremy Gililland, MD

Orthopaedic Surgery · Salt Lake City, UTNPI 1881849669

Payments from drug & device makers

$3,344,919in general payments, 2019–2025

Across 836 payments — averaging $4001.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$1.8M
  • Zimmer Biomet$1.4M
  • Orthogrid Systems Inc$140K
  • Encore Medical, LP$22K
  • Solventum Corporation$16K
  • Medacta USA, Inc.$9K
  • plus $15K from 10 others
$1,035in research payments, 2019–2025

Across 1 payment — averaging $1034.67 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Zimmer Biomet$1K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,344,919 in reported general payments places this provider in the 95th percentile of 221 orthopaedic surgery providers in Utah.

See all orthopaedic surgery providers in Utah

Medicare billing

Part B allowed, 2024
$238,101
Medicare patients
406
Services billed
878

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other orthopaedic surgery in Salt Lake City

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →